Skip to main content
logo
Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
28.55
-3.48 (-10.86%)
Aug 20, 2026, 4:00 PM EDT - Market closed

Apnimed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
120.1538.478.01-1
Revenue Growth
-380.12%---
Cost of Revenue
7.546.693.37--
Gross Profit
112.6131.774.64-1
Selling, General & Admin
24.5323.4921.511.316.63
Research & Development
46.7562.197.3837.2120.92
Operating Expenses
71.2885.59118.8848.5227.55
Operating Income
41.34-53.82-114.23-48.52-26.55
Interest & Investment Income
1.21.415.685.770.47
Earnings From Equity Investments
----37.5-
Other Non Operating Income (Expenses)
-5.65-5.65---0.13
Pretax Income
39-58.05-108.55-80.25-26.21
Income Tax Expense
--0.05--
Earnings From Continuing Operations
39-58.05-108.6-80.25-26.21
Earnings From Discontinued Operations
-70.83-70.14-2.7--
Net Income
-31.83-128.19-111.31-80.25-26.21
Net Income to Common
-31.83-128.19-111.31-80.25-26.21
Net Income Growth
-----
Shares Outstanding (Basic)
55532
Shares Outstanding (Diluted)
55532
Shares Change
-0.49%86.29%21.39%-
EPS (Basic)
-5.88-23.76-20.73-27.84-11.04
EPS (Diluted)
-6.28-23.76-20.73-27.84-11.04
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-69.19-77.83-110.2825.37-26.13
Free Cash Flow Per Share
-12.79-14.42-20.548.80-11.00
Gross Margin
93.73%82.60%57.95%-100.00%
Operating Margin
34.41%-139.91%-1425.79%--2654.80%
Profit Margin
-26.49%-333.25%-1389.23%--2620.80%
Free Cash Flow Margin
-57.59%-202.33%-1376.42%--2612.90%
EBITDA
41.36-53.79-114.21-48.52-
EBITDA Margin
34.43%-139.84%---
D&A For EBITDA
0.030.030.020-
EBIT
41.34-53.82-114.23-48.52-26.55
EBIT Margin
34.41%-139.91%---
SEC Filings: 10-K · 10-Q